Schedule of Computation of Basic and Dilute Net EPS |
The following table shows the computation of the Company’s basic and diluted net EPS of common stock for the periods presented below (in thousands, except share and per share amount).
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Years |
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss attributable to common stockholders - basic |
|
|
|
|
|
|
|
$ |
(214,071) |
|
|
$ |
(51,622) |
|
|
$ |
(125,874) |
|
Decrease in fair value of Private Placement Warrants |
|
|
|
|
|
|
|
(6,180) |
|
|
(75,180) |
|
|
— |
|
Net loss attributable to common stockholders - diluted |
|
|
|
|
|
|
|
$ |
(220,251) |
|
|
$ |
(126,802) |
|
|
$ |
(125,874) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average shares outstanding used in computing net loss per share of common stock, basic |
|
|
|
|
|
|
|
159,065,697 |
|
|
152,918,287 |
|
|
117,218,893 |
|
Dilutive effect of Private Placement Warrants |
|
|
|
|
|
|
|
509,858 |
|
|
1,231,080 |
|
|
— |
|
Weighted-average shares outstanding used in computing net loss per share of common stock, diluted |
|
|
|
|
|
|
|
159,575,555 |
|
|
154,149,367 |
|
|
117,218,893 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share of common stock: |
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
|
|
|
|
|
$ |
(1.35) |
|
|
$ |
(0.34) |
|
|
$ |
(1.07) |
|
Diluted |
|
|
|
|
|
|
|
$ |
(1.38) |
|
|
$ |
(0.82) |
|
|
$ |
(1.07) |
|
|
Schedule of Anti-Dilutive Securities Excluded From Computation of Diluted Loss Per Share |
As the Company reported net loss for the periods presented above, these potentially dilutive securities were anti-dilutive and were excluded in the computation of diluted net loss per share. The following table discloses shares of the securities that were not included in the diluted EPS calculation above because they were anti-dilutive for the periods presented above.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Years |
|
|
|
|
|
|
|
|
2023 |
|
2022 |
|
2021 |
Stock options outstanding |
|
|
|
|
|
|
|
2,615,199 |
|
|
5,034,282 |
|
|
5,753,005 |
|
Restricted stock units and performance restricted stock units outstanding |
|
|
|
|
|
|
|
11,424,740 |
|
|
7,371,158 |
|
|
535,449 |
|
Private Placement Warrants outstanding |
|
|
|
|
|
|
|
— |
|
|
— |
|
|
6,000,000 |
|
Public Warrants outstanding |
|
|
|
|
|
|
|
— |
|
|
— |
|
|
4,322,106 |
|
Employee stock purchase plan estimated shares |
|
|
|
|
|
|
|
442,146 |
|
|
349,988 |
|
|
47,379 |
|
Assumed conversion of Convertible Senior Notes |
|
|
|
|
|
|
|
11,053,800 |
|
|
— |
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|